Testing effectiveness (Phase 2)Looking for participantsNCT05675813What this trial is testingGenotype-guided Treatment in Newly Diagnosed PTCLWho this might be right forPeripheral T Cell Lymphoma Ruijin Hospital 264
Testing effectiveness (Phase 2)Study completedNCT03794167What this trial is testingBuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's LymphomaWho this might be right forNon-hodgkin Lymphoma Soonchunhyang University Hospital 75
Not applicableEnded earlyNCT01663571What this trial is testingSTAT3 in T Cells: At The Crossroads of Inflammation and CancerWho this might be right forCutaneous T Cell Lymphoma NYU Langone Health 35
Not applicableLooking for participantsNCT02682667What this trial is testingBiospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsWho this might be right forMultiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-Cell+2 more National Cancer Institute (NCI) 500
Early research (Phase 1)Looking for participantsNCT06792734What this trial is testingPhase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell LymphomasWho this might be right forLymphoma, B-Cell Bantam Pharmaceuticals 24
Early research (Phase 1)Study completedNCT01032681What this trial is testingEMD 521873 in Advanced Solid Tumors, MTD FindingWho this might be right forNon-Hodgkin Lymphoma Merck KGaA, Darmstadt, Germany 66
Very early researchUnknownNCT06277011What this trial is testingSafety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical ResearchWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma Anhui Provincial Hospital 18
Early research (Phase 1)Study completedNCT00646139What this trial is testingKX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to TreatmentWho this might be right forLymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more Roswell Park Cancer Institute 7
Large-scale testing (Phase 3)Looking for participantsNCT07409428What this trial is testingA Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCLWho this might be right forRelapsed/Refractory Diffuse Large B-Cell Lymphoma Hutchmed 240
Testing effectiveness (Phase 2)Ended earlyNCT00479167What this trial is testingA Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's LymphomaWho this might be right forFollicular Lymphoma Rush University Medical Center 1
Early research (Phase 1)Study completedNCT02859207What this trial is testingEvaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy SubjectsWho this might be right forEarly Alzheimer's Disease Eisai Inc. 32
Not applicableUnknownNCT03564977What this trial is testingCD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell TransplantationWho this might be right forLymphoma, B-CellLeukemia, B-CellMinimal Disease, Residual Qingdao Central Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05875428What this trial is testingMitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-Cell Lymphoma CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 104
Testing effectiveness (Phase 2)Looking for participantsNCT05868395What this trial is testingEfficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell LymphomaWho this might be right forMantle-cell Lymphoma Medical University of Vienna 16
Testing effectiveness (Phase 2)Study completedNCT00003957What this trial is testingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's LymphomaWho this might be right forLymphoma Fox Chase Cancer Center 3
Not applicableLooking for participantsNCT07528781What this trial is testingNovel 3-dimensional Echocardiographic Quantification of Mitral Regurgitant VolumeWho this might be right forModerate or Severe Mitral Regurgitation Germans Trias i Pujol Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Early research (Phase 1)Ended earlyNCT00376519What this trial is testingUmbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT02484430What this trial is testingSapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative+3 more National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT01068392What this trial is testingOxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)Who this might be right forB-cell Lymphomas Dong-A University Hospital 42